Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 15Unspecified Adult Solid Tumor, Protocol Specific 3Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Precancerous Conditions 2Pancreatic Neoplasms 2Neoplasms 2Hypocalcemia 2Vitamin D Deficiency 1Tuberous Sclerosis 1Tobacco Use Disorder 1Thyroiditis 1Thyroid Nodule 1Thyroid Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia 1Pinealoma 1Osteoporosis 1Oligodendroglioma 1Obesity 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Mouth Neoplasms 1Meningioma 1Melanoma 1Medulloblastoma 1Leukemia 1Hyperthyroidism 1Hyperplasia 1

Interventions

Methylprednisolone 3Etanercept 2tocilizumab 1pirfenidone 1ceftolozane, tazobactam drug combination 1XAV-19 1Ultrasonography 1Standard of Care 1Sodium Bicarbonate 1Saline Solution 1Ribavirin 1Prednisone 1Nebulizers and Vaporizers 1Lidocaine 1Immunoglobulin G 1Gelsolin 1Fluoridation 1Disulfides 1Clinical Protocols 1Calcitriol 1CIMAvax EGF 1Blood Specimen Collection 1Amifostine 1Adrenal Cortex Hormones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pneumonia × Calcitriol × Clear all
NCT03469271 2023-09-26

Maintain Respiratory Muscle Function and Reduce Pneumonia Risk in Cancer Patients

Mayo Clinic

Phase 4 Completed
63 enrolled 8 charts

Neoplasms, Pneumonia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡